Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

745 results about "Infectious Disorder" patented technology

Infectious disorders alsoinfectious disease is a clinically evident condition resulting from the presence of pathogenic microbial agents, including viruses, bacteria, fungi, protozoa, multicellular parasites, and aberrant proteins known as prions. These pathogens are able to cause disease in animals and/or plants.

Respiratory infectious disease transmission risk assessment method based on multi-person dynamic scene

The invention relates to a respiratory infectious disease transmission risk assessment method based on a multi-person dynamic scene. The method sequentially comprises the steps of building models of a risk assessment object and a research area, setting analysis parameters according to infection source characteristics, setting crowd movement parameters, carrying out numerical simulation aiming at diffusion of infectious substances, calculating a personnel exposure level and carrying out infectious disease infection risk comprehensive assessment. Building models of the risk assessment object and the research area, to be specific, building a calculation area of a multi-person dynamic scene where the respiratory infectious disease occurs, and performing calculation grid division on the area to build a calculation model; analysis parameters are set according to characteristics of infection sources, release characteristics of the infection substances from different areas of the respiratory system of a patient are considered, different infection source types and exhalation characteristics are set according to different scenes, then the process of exhalation of the infection substances and aerodynamic characteristics of the process are simulated, and a result with universality is constructed to serve as an input module.
Owner:NANJING TECH UNIV +1

Application of supramolecular fluorescence sensing array in aspect of intracellular bacteria identification

The invention relates to a supramolecular fluorescence sensing array, which provides rapid and accurate diagnosis for infection types of bacteria in cells. Eight azo calixarenes carrying different upper edge modifications are designed and synthesized, including sugar modification, amino acid modification, sulfonic acid modification and carboxyl modification, and have differential interaction with different intracellular bacteria. The azo calixarene loaded fluorescent indicators form a sensing unit, and the sensing array can distinguish and distinguish eight representative intracellular bacteria without cell lysis by integrating various signal change pathways. The correct identification of bacteria in the blind sample cells is convenient for accurate diagnosis, and guidance is provided for selecting proper antibiotics. The supramolecular method provided by the invention can provide a reference method and basis for promoting diagnosis and guidance treatment of bacterial infectious diseases in clinical practice.
Owner:NANKAI UNIV

Self-Assembling Nanoparticles Based On Amphiphilic Peptides for Drug Delivery Applications

The present disclosure relates to a composition comprising a first amphiphile and optionally a second amphiphile each having the formula S-[B]-[U]-H-[D] and at least one drug molecule is noncovalently associated with or covalently bonded directly or via a suitable linker X1 to the first amphiphile and / or to the optional second amphiphile. The composition is useful in treating a cancer, an infectious disease or an inflammatory disease.
Owner:THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH & HUMAN SERVICES +1

Primer combination and kit for real-time fluorescent quantitative PCR detection of pertussis bordetella 23S rRNA drug-resistant site variation

The invention discloses a primer combination and a kit for real-time fluorescent quantitative PCR detection of Bordetella pertussis 23S rRNA drug-resistant site variation, and the primer combination comprises a target point amplification primer group, a wild type fluorescent probe and a mutant type fluorescent probe, and can also comprise an internal reference amplification primer group and an internal reference detection fluorescent probe, the kit disclosed by the invention can be used for real-time fluorescent quantitative PCR detection of drug-resistant site variation of 23S rRNA of the bordetella pertussis, so that a detection result about whether the bordetella pertussis exists or not and the drug resistance of erythromycin can be obtained. The detection result has the advantages of high accuracy, high sensitivity, short detection window period and the like, can be applied to the fields of clinical diagnosis, public health monitoring, scientific research and the like, improves the detection efficiency and drug resistance detection level of pertussis infectious diseases, provides a scientific basis for prevention, control and treatment of pertussis infection, and has a wide application prospect. The method has important application value and wide market prospect.
Owner:WUHAN ADICON CLINICAL LAB

Animal remains processing device

The invention belongs to the related technical field of animal remains treatment, and discloses an animal remains treatment device which comprises a box body, a spraying unit is arranged at the top of the box body, a soaking and freezing unit is arranged below the spraying unit, animal remains are placed in the soaking and freezing unit, and the animal remains are conveyed to a vacuum drying unit after being sprayed, soaked and frozen. And performing crushing treatment after drying. Two-phase heat exchange of liquid nitrogen spraying is utilized, quick freezing of the remains is achieved, then liquid nitrogen is utilized for soaking, and ductile-brittle transformation of animal remains tissue is achieved; sublimation of water in the remains is achieved through negative pressure, drying of the animal remains is achieved, mechanical damage is reduced to the maximum extent, pathogens and bacteria can be effectively killed through liquid nitrogen freezing and smashing, and therefore the risk of infectious diseases is reduced.
Owner:HUAZHONG UNIV OF SCI & TECH

Multiple qPCR primer probe set, detection system and kit for detecting duck enteritis virus, goose parvovirus and muscovy duck parvovirus and application

The invention provides a multiple qPCR (quantitative polymerase chain reaction) primer probe group for detecting duck enteritis virus, goose parvovirus and muscovy duck parvovirus, a detection system, a kit and application, and belongs to the technical field of virus detection. The multiplex qPCR detection primer probe group comprises an upstream primer DEV-F, a downstream primer DEV-R and a fluorescent probe DEV-Probe, wherein the upstream primer DEV-F, the downstream primer DEV-R and the fluorescent probe DEV-Probe are used for detecting the duck enteritis virus; the upstream primer GPV-F, the downstream primer GPV-R and the fluorescent probe GPV-Probe are used for detecting goose parvovirus, and the upstream primer MDPV-F, the downstream primer MDPV-R and the fluorescent probe MDPV-Probe are used for detecting muscovy duck parvovirus. The primer probe group provided by the invention has good specificity and sensitivity, can simultaneously detect three waterfowl infectious disease pathogens, has no cross reaction among the three pathogens, and is high in stability, and the coefficient of variation is below 10%.
Owner:CHINA INST OF VETERINARY DRUG CONTROL

Preparation method of silicon-coated gold nanorod coated with protein halo and PCR (polymerase chain reaction) amplification method and kit based on silicon-coated gold nanorod coated with protein halo

The invention discloses a preparation method of a protein halo-coated silicon-coated gold nanorod and a PCR amplification method and kit based on the protein halo-coated silicon-coated gold nanorod, and belongs to the technical field of PCR detection. The photo-thermal nano material is composed of an AuNR coated SiO2 core-shell structure and an external protein halo layer, the protein halo layer avoids inhibition of AuNR on a PCR reaction system, meanwhile, adsorption of AuNR on biological small molecules is effectively reduced, non-specific amplification is reduced, and normal amplification of PCR reaction is guaranteed; and the protein halo layer is used as a thermal insulation layer to optimize heat exchange and maintain the temperature uniformity of the reaction liquid. When the kit is applied to a photo-thermal PCR detection reagent, DNA of a pathogen to be detected can be efficiently and stably amplified and detected within 10 minutes, the kit has huge application potential in the fields of early screening of infectious diseases, food safety detection and the like, collaborative optimization of photo-thermal conversion efficiency, biocompatibility, detection sensitivity and operation convenience is achieved, and the kit has a wide application prospect. And an efficient solution is provided for prevention and control of infectious diseases, food safety monitoring and biomedical research.
Owner:XI AN JIAOTONG UNIV

Respiratory infectious disease multi-pathogen nucleic acid detection kit based on fluorescent PCR detection technology and application thereof

The invention discloses a respiratory infectious disease multi-pathogen nucleic acid detection kit based on a fluorescent PCR detection technology and application of the respiratory infectious disease multi-pathogen nucleic acid detection kit. The invention provides two detection kits aiming at 20 and 6 respiratory tract detection, the two kits can specifically detect respiratory tract pathogens, the detection sensitivity is high, the whole detection system is short in time consumption and simple and convenient in use process, and detection results of 20 pathogenic microorganisms can be reported within 40 min at the shortest; the whole set of detection kit and the detection method are high in sensitivity and good in specificity; the normal-temperature storage and transportation of the reagent can be realized.
Owner:THE CHILDRENS HOSPITAL ZHEJIANG UNIV SCHOOL OF MEDICINE

Multiple qPCR primer probe set for detecting duck tembusu virus, duck reovirus, duck hepatitis A virus type 1 and duck hepatitis A virus type 3, detection system and application

The invention provides a multiple qPCR (quantitative polymerase chain reaction) primer probe group for detecting a duck tembusu virus, a duck reovirus, a duck hepatitis A virus type 1 and a duck hepatitis A virus type 3, a detection system and application, and belongs to the technical field of virus detection. The multiplex qPCR detection primer probe group comprises an upstream primer, a downstream primer and a fluorescent probe which are used for detecting the duck tembusu virus, the upstream primer, the downstream primer and the fluorescent probe are used for detecting the duck reovirus; the upstream primer, the downstream primer and the fluorescent probe are used for detecting the duck hepatitis A virus type 1, and the upstream primer, the downstream primer and the fluorescent probe are used for detecting the duck hepatitis A virus type 3. The primer probe group disclosed by the invention has good specificity and sensitivity and can be used for simultaneously detecting four waterfowl infectious disease pathogens.
Owner:CHINA INST OF VETERINARY DRUG CONTROL

Primer probe group, gene chip, kit and application for detecting seven waterfowl infectious disease pathogens

The invention relates to the field of pathogen detection, in particular to a primer probe group, a gene chip and a kit for detecting seven waterfowl infectious disease pathogens and application. The primer probe group provided by the invention can be used for simultaneously detecting the goose parvovirus, the duck viral enteritis virus, the muscovy duck parvovirus, the duck hepatitis A virus type 1, the duck hepatitis A virus type 3, the duck tembusu virus and the novel duck reovirus, and is strong in specificity and high in sensitivity. Furthermore, a gene chip prepared by using the primer probe group provided by the invention not only has strong specificity and high sensitivity (1.0 * 100 copies / [mu] L), but also has good repeatability and stability, can be stably stored within at least 180 days, has sensitivity superior to that of a standard fluorescent quantitative PCR method, can rapidly and efficiently detect main epidemic disease pathogens of waterfowl together, and has good application prospects. The method can be used for epidemiological investigation and disease diagnosis of waterfowls.
Owner:CHINA INST OF VETERINARY DRUG CONTROL

Multispecific proteins binding to nkp46, a cytokine receptor, a tumour antigen and CD16a

Multispecific proteins that bind NKp46 and specifically redirect effector cells to lyse a target cell of interest via multiple receptors are provided. The proteins have utility in the treatment of disease, notably cancer or infectious disease.
Owner:INNATE PHARMA SA

One-pot rapid nucleic acid detection system based on SfaTnpB combined isothermal amplification technology and application of one-pot rapid nucleic acid detection system

The invention relates to the technical field of nucleic acid on-site rapid visual detection, in particular to a one-pot rapid nucleic acid detection system based on an SfaTnpB combined isothermal amplification technology and application of the one-pot rapid nucleic acid detection system. According to the invention, an RAA isothermal amplification technology and an LAMP isothermal amplification technology are respectively combined with SfaTnpB nuclease, and finally, an RAA-SfaTnpB one-pot method system and an LAMP-SfaTnpB one-pot method system are successfully established. The one-pot system established by the invention has the advantages of high sensitivity, high specificity, fast reaction, strong accuracy and no need of complex equipment, the detection result can be visually interpreted by naked eyes, the system has high convenience and practicability, the adaptability and practicability of the system are further improved, and the rapid detection requirements in various scenes can be flexibly met. The system has a wide application prospect in the fields of rapid pathogen detection, genotype detection, early diagnosis of infectious diseases and the like.
Owner:YAZHOUWAN NATIONAL LABORATORY +1

Solid-phase agglutination detection reagent card and detection method thereof

The invention provides a solid-phase agglutination detection test paper card and a detection method thereof. A reaction area of the solid-phase agglutination detection test paper card comprises a reaction film, the reaction film is coated with captured protein and can enrich to-be-detected antibodies in a to-be-detected sample, and the captured protein is combined with the to-be-detected antibodies and then subjected to agglutination reaction with granular antigens in a detection reagent to form an agglutination compound. And the agglutination compound is intercepted in the reaction film for color development. The granular antigen is a cell carrying a specific antigen or a conjugate formed by coupling the specific antigen and an inert carrier, and the granular antigen can be colored or has a luminescence property in various modes. The solid-phase agglutination detection test paper card provided by the invention has the advantages of simple detection steps, short detection time, high sensitivity, accurate detection result, strong specificity and the like, can be used for detecting various diseases and monitoring antibody level, and also has important significance in the fields of infectious disease prevention and control, medical diagnosis and the like.
Owner:INST OF ANIMAL SCI & VETERINARY TIBET ACADEMY OF AGRI & ANIMAL HUSBANDRY SCI +2

Multifunctional antibody-ligand traps to counteract immune tolerance

The invention provides multifunctional antibody-ligand traps and methods of using them to counteract immune tolerance and / or immune dysfunction. The multifunctional antibody-ligand traps and fusion proteins of the invention can counteract immune dysfunction in order to restore and unleash antitumor or pathogen-directed immune responses. Provided here are promising immunotherapeutic agents for treatment and prevention of cancers, infectious diseases, and immuno-inflammatory disorders.
Owner:JOHNS HOPKINS UNIVERSITY

Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response

Provided herein are Toll-like receptor 2 (TLR2) agonists for use in enhancing human immune response and / or as adjuvants in vaccines. The TLR2 agonists include thiophenes, imidazoles, or phenyl-containing compounds, which may be compounds of Formulae (I), (II), (III), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. The compounds described herein are used as enhancers of an immune response (e.g., innate and / or adaptive immune response), and are useful in treating and / or preventing a disease, as adjuvants in a vaccine for the disease. (e.g., proliferative disease, inflammatory disease, autoimmune disease, infectious disease, or chronic disease). Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.
Owner:CHILDRENS MEDICAL CENT CORP +1

Infectious disease infection prediction method and device based on macrograph-micrograph fusion, and storage medium

An infectious disease infection prediction method and device based on macrograph-micrograph fusion, and a storage medium. The method comprises: acquiring macrographs of a plurality of first areas and micrographs of second areas in a certain set time period; respectively inputting the macrographs and the micrographs into a first graph convolutional neural network and a second graph convolutional neural network to respectively obtain a first hidden layer vector and a second hidden layer vector, and fusing the first hidden layer vector and the second hidden layer vector to obtain fused hidden layer information of each first area; performing temporal calculation on the fused hidden layer information to obtain temporal hidden layer information of each first area, and separately inputting the temporal hidden layer information into two prediction networks to obtain two prediction results; and performing fusion calculation on the two prediction results to obtain a final infectious disease prediction result for each first area.
Owner:ZHEJIANG LAB

Recombinant protein for SARS-COV2 disease

The present invention relates to the protein for treatment of infectious disease caused by Coronaviridae. In particular, the invention relates to a recombinant Sclerotium rolfsii lectin for use in the treatment, reduction in progression and curing of SARS-COV2 disease in a subject in need thereof. Pharmaceutical compositions comprising said recombinant Sclerotium rolfsii lectin are also described. The recombinant Sclerotium rolfsii lectin protein may comprise an amino acid sequence having at least 70% homology to SEQ ID NO: 1.
Owner:UNICHEM LAB LTD

Peptide inhibitors of trim7 and uses thereof

The present disclosure relates to compositions and methods, including Trim / inhibitors that find use in the treatment of disease, such as therapies for cancer, including cancers that are resistant to anti-checkpoint agents, infectious diseases and inflammatory diseases.
Owner:SHATTUCK LABS INC

Bacillus thuringiensis strain, fermentation culture method and application of bacillus thuringiensis strain

PendingCN121362705ABiocideBacteriaCulexInfectious Disorder
The invention provides a bacillus thuringiensis strain, a fermentation culture method and application of the bacillus thuringiensis strain. The strain is preserved in the China Center for Type Culture Collection on September 28, 2011, the preservation address is No. 299 on eight road, Wuchang District, Wuhan City, Hubei Province, the preservation number is CCTCC No: M 2011334, and the preservation date is September 28, 2011. The strain cultured by the fermentation method has efficient, specific and stable insecticidal activity on culex, aedes and other mosquitoes, has the advantages of low preparation cost, environmental friendliness and the like, can be developed into a biological insecticide for preventing and killing mosquitoes and preventing and controlling malaria, dengue fever, chikungunya and other mosquito-borne infectious diseases, and meets the requirements of green and safe prevention and control in China.
Owner:KONO BIOLOGY (HUBEI) CO LTD +1

Heterocyclic compounds, preparation methods and uses thereof

Provided herein are compounds, crystalline forms, and pharmaceutical compositions of Compound 1 and / or Compound 2. Also provided are methods of treating a disease or disorder such as a cancer or infectious disease that comprises administering to a subject in need thereof one or more of the compounds or compositions of the present disclosure.
Owner:INVENTISBIO CO LTD

Immunity-enhancing peptide analogs and uses thereof

The present invention relates to a WKYMVm peptide analog comprising an amino acid sequence of Trp (W)-Lys (K)-Tyr (Y)-Met (M)-Val (V)-D-Met (m), in which at least one amino acid residue selected from the group consisting of Lys (K), Tyr (Y), and Met (M) in the amino acid sequence is substituted with a β3-amino acid residue or a peptoid residue, and a use thereof. The WKYMVm peptide analogs of the present invention has effects of increasing stability by increasing in vivo degradation half-life and of promoting activation of innate immune responses by neutrophils through activation of formyl peptide receptors, and thus can be effectively used in preventing or treating a disease that is be prevented or treated by formyl peptide receptors, especially an infectious disease or inflammatory disease.
Owner:RES & BUSINESS FOUND SUNGKYUNKWAN UNIV +1

Recombinant collagen and application thereof

ActiveCN118994373Areduce riskEnsure a high degree of similarityConnective tissue peptidesFungiInfectious DisorderBiocompatibility
The invention relates to the field of bioengineering and biomedical materials, in particular to recombinant collagen and application thereof. According to the present invention, the recombinant collagen is constructed by using the amino acid sequence of the human-derived III-type collagen and carrying out sequence optimization and integration on the basis of the amino acid sequence through the gene engineering technology, and the amino acid sequence of the recombinant collagen is represented by SEQ ID No. 1 or SEQ ID No. 2; the recombinant collagen has better biocompatibility and biosafety, and is an innovative product with potential application prospects. The problems of provenance limitation, immunogenicity, infectious disease risk and the like of animal-derived collagen are solved, and a new direction is provided for development of collagen products. Meanwhile, the recombinant collagen can be applied to preparation of skin wound healing products, and has important application value and wide market prospect.
Owner:江苏奥普莱医疗用品有限公司

Solid-phase agglutination detection test paper card directly marked by antigen and detection method of solid-phase agglutination detection test paper card

PendingCN120908434ABiological testingInfectious DisorderParticulate antigen
The invention provides a solid-phase agglutination detection test paper card directly marked by antigens and a detection method thereof. A reaction area of the solid-phase agglutination detection test paper card comprises a reaction film, the reaction film is coated with captured protein and can enrich to-be-detected antibodies in a to-be-detected sample, and the captured protein is combined with the to-be-detected antibodies and then subjected to agglutination reaction with granular antigens in a detection reagent to form an agglutination compound. And the agglutination compound is intercepted in the reaction film for color development. The granular antigen is a conjugate formed by coupling a specific antigen and an inert carrier, the specific antigen is not a protein, and the specific antigen is specifically combined with an antibody to be detected. The solid-phase agglutination detection test paper card provided by the invention has the advantages of simple detection steps, short detection time, high sensitivity, accurate detection result, strong specificity and the like, can be used for detecting various diseases and monitoring antibody level, and also has important significance in the fields of infectious disease prevention and control, medical diagnosis and the like.
Owner:INST OF ANIMAL SCI & VETERINARY TIBET ACADEMY OF AGRI & ANIMAL HUSBANDRY SCI +2

Detection test paper and detection kit for detecting IgG / IgM antibody

The invention provides detection test paper and a detection kit for detecting an IgG / IgM antibody. The detection test paper comprises a marking pad, a sample pad, a detection pad and a water absorption pad which are adhered to a bottom card and are sequentially overlapped from upstream to downstream, the detection pad is coated with an IgG detection line and an IgM detection line, and the IgG detection line is located at the upstream of the IgM detection line; during detection, the sample reaches the detection line of the detection pad before the marker. The detection test paper is simple in structure, convenient to use, high in anti-interference capacity and high in detection sensitivity, and the detection kit can improve the accuracy, early diagnosis and early treatment of early diagnosis of diseases such as infectious diseases, so that transmission of the infectious diseases is reduced.
Owner:ACON BIOTECH (HANGZHOU) CO LTD

Early warning method and system for new respiratory infectious diseases

The invention relates to the technical field of infectious disease detection, and discloses a new respiratory infectious disease early warning method, which comprises the following steps: S1, specimen collection and data collection: collecting biological samples of new respiratory infectious disease virus infected individuals and other respiratory infectious disease virus infected individuals, the biological sample comprises a blood sample and a swab sample; meanwhile, basic information of the individuals is collected, wherein the basic information comprises gender, age and respiratory symptom duration; s2, quantitative detection: the biological sample is subjected to quantitative detection by adopting reagents of various respiratory infectious disease viruses, the detection content comprises antigens and antibodies, and the antibodies comprise an I gM antibody, an I gG antibody and an I gA antibody; according to the invention, basic information of individuals and antigen-antibody detection reagent resources of various respiratory infectious disease viruses are deeply integrated, so that the recognition capability of new respiratory infectious disease virus infected individuals is effectively improved.
Owner:GUANGDONG PROVINCIAL INST OF PUBLIC HEALTH

Rapid detection and intelligent early warning system for port concerned infectious diseases

The invention discloses a rapid detection and intelligent early warning system for port concerned infectious diseases, and relates to the field of customs quarantine, and the system comprises a target selection unit, a construction unit, a modification unit, an amplification unit, a purification unit, a determination unit and a detection unit. According to the invention, through systematic improvement in the aspects of multi-primer design and modification, amplification system optimization, product purification, multi-dimensional scoring decision and the like, many defects in the aspects of multi-pathogen detection, dimer interference suppression, detection efficiency and sensitivity improvement in the prior art are overcome; rapid, efficient and intelligent screening and real-time early warning of port concerned infectious diseases are realized.
Owner:四川国际旅行卫生保健中心(成都海关口岸门诊部)

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Provided are antibodies that specifically bind to Programmed Death-1 (PD1, Pdcd-1, or CD279) and inhibit PD1-mediated cellular signaling and activities in immune cells, antibodies binding to a set of amino acid residues required for its ligand binding, and uses of these antibodies to treat or diagnose cancer, infectious diseases or other pathological disorders modulated by PD1-mediated functions.
Owner:BEIGENE LTD